Smoking cessation products are now available for pharmacy order on Canview. Log in to learn more.
With the recent TGA reform changes, the demand for smoking cessation products is expected to increase.
Our free-to-use online platform simplifies the process, so you can provide these essential products to your patients effortlessly.
Prepare your pharmacy today by placing a wholesale order with Canview.
Explore Canview’s range of smoking cessation products, tailored to meet the increasing demand throughout Australia. These products offer everything you need to support your patients with pharmacotherapy for smoking cessation.
We currently stock compliant products from reputable suppliers of smoking cessation products in Australia, including Bay Pharma and From the Fields.
Understanding how to assist your patients on their journey to quit smoking is essential. Visit our Education Hub for clinical resources to upskill yourself in the fundamentals of smoking cessation.
Resources include downloads about product guidelines and the SAS-C process.
Getting familiar with new technology can be daunting. Our team are here to support you every step of the way with ongoing training and support.
Have questions about accessing smoking cessation products in Australia for your pharmacy? Browse our FAQs below.
If you’re interested in learning how to navigate the regulatory environment, read our article on Australia’s smoking cessation regulations.
To order smoking cessation products for your pharmacy, log in to your Canview account, click on “Catalogue” and then click on the “bulk products” tab. The wholesale price (ex GST) will be for product packs (usually containing 5-10 units per pack). The recommended retail price (inc GST, if applicable) is for a single unit.
Yes, smoking cessation products for patients 18 years or older or those with a concentration of 20 mg/ml or less can be stocked on shelf at your pharmacy without the requirement of a script or approval in Australia.
Therefore, pharmacies can conveniently keep this stock on hand for patients and immediately dispense.
Smoking cessation products for patients under 18 years old or those containing a concentration over 20 mg/ml will continue to require a prescription from a medical or nurse practitioner, subject to state and territory laws.
The advertising of therapeutic goods, including smoking cessation products, is generally prohibited in Australia. Some states and territories also restrict the promotion of nicotine vaping devices.
However, some states and territories allow pharmacists to notify patients in a specified manner if they supply nicotine vaping devices.
Check with local state health departments to determine applicable laws.
The 1st of January 2024 signified the first stage of reform to create a truly medical pathway for access to smoking cessation products in Australia.
From 1 January 2024, the government will progress a ban on the importation of disposable single use products, both therapeutic and non-therapeutic.
To enhance drug control, the government is implementing the requirement for importers of therapeutic smoking cessation products to obtain a licence and permit from the Office of Drug Control.
A new SAS pathway will also be commenced to enable medical practitioners and nurse practitioners to prescribe therapeutic vapes, where clinically appropriate.
This pathway will facilitate improved patient access to therapeutic vapes, without requiring pre-approval or authority from the TGA.
To read more, click here.
The 1st of March 2024 brought a ban on the importation of all non-therapeutic products and an end to the personal importation scheme.
From 1 July 2024, smoking cessation vape products are classified as therapeutic goods, regulated by the Therapeutic Goods Administration (TGA). These products are now sold exclusively in pharmacies and require a prescription from a licensed healthcare provider. This regulation aims to ensure appropriate access for nicotine dependence management.
The following key legislation changes became effective on 1 October 2024, regarding the access and regulation of smoking cessation products in Australia.
Smoking cessation products with ≤20mg/mL nicotine became available in Australian pharmacies without a prescription for patients 18 years or older, if deemed appropriate by a pharmacist. This reclassified these products from Schedule 4 (prescription only) to Schedule 3 (pharmacist only).
2. Continued prescription requirements
Products for patients under 18 or with nicotine concentrations >20mg/mL will still require a prescription from a medical or nurse practitioner, following state and territory laws.
Supply of smoking cessation products will be subject to no restrictions in order quantities.
Cartons will be the smallest ordering item and typically contain 5-10 units. This reflects a patient’s requirement for replenishing smoking cessation products.
Canview will outline each of the supplier’s packaging and order requirements.
"*" indicates required fields
A facilitation agent for BHC.